Literature DB >> 30876963

Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping.

Scott McHenry1, Yeshika Sharma2, Ankita Tirath3, Richard Tsai4, Aaron Mintz4, Tyler J Fraum4, Amber Salter5, Jeffrey D Browning6, Avegail G Flores1, Nicholas O Davidson1, Kathryn J Fowler7, Matthew A Ciorba8, Parakkal Deepak9.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) commonly coexists with Crohn's disease (CD); however, it remains unclear if it is more prevalent than would be expected as ultrasound surveys of CD patients report a very wide range of prevalence (9%-40%).1-3 To address this uncertainty, we performed a prospective, cross-sectional survey of NAFLD in CD patients by generating magnetic resonance proton density fat fraction (MR-PDFF) maps as compared with 2 control populations. MR-PDFF provides a quantitative, sensitive and specific (97% and 100%, respectively) radiographic surrogate for liver fat.4.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 30876963      PMCID： PMC7539260          DOI： 10.1016/j.cgh.2019.02.045

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  8 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto.

Authors:  G Riegler; R D'Incà; G C Sturniolo; G Corrao; C Del Vecchio Blanco; V Di Leo; R Carratù; M Ingrosso; M A Pelli; S Morini; D Valpiani; D Cantarini; P Usai; C Papi; R Caprilli
Journal:  Scand J Gastroenterol       Date:  1998-01       Impact factor: 2.423

3.  A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

Authors:  Ilkay S Idilman; Onur Keskin; Azim Celik; Berna Savas; Atilla Halil Elhan; Ramazan Idilman; Musturay Karcaaltincaba
Journal:  Acta Radiol       Date:  2015-04-08       Impact factor: 1.990

4.  Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.

Authors:  Mariabeatrice Principi; Andrea Iannone; Giuseppe Losurdo; Michela Mangia; Endrit Shahini; Francesca Albano; Salvatore Fabio Rizzi; Rosa Federica La Fortezza; Rosa Lovero; Antonella Contaldo; Michele Barone; Gioacchino Leandro; Enzo Ierardi; Alfredo Di Leo
Journal:  Inflamm Bowel Dis       Date:  2018-06-08       Impact factor: 5.325

5.  Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center.

Authors:  Stefano Bargiggia; Giovanni Maconi; Marco Elli; Paola Molteni; Sandro Ardizzone; Fabrizio Parente; Ivan Todaro; Salvatore Greco; Guendalina Manzionna; Gabriele Bianchi Porro
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

Review 6.  OsiriX: an open-source software for navigating in multidimensional DICOM images.

Authors:  Antoine Rosset; Luca Spadola; Osman Ratib
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

7.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

8.  Epidemiology of Hepatic Steatosis at a Tertiary Care Center: An MRI-based Analysis.

Authors:  Tyler J Fraum; Daniel R Ludwig; Scott Kilian; William A Curtis; Thomas K Pilgram; Claude B Sirlin; Kathryn J Fowler
Journal:  Acad Radiol       Date:  2017-12-02       Impact factor: 3.173
  8 in total
  4 in total

1.  Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease.

Authors:  Lanlan Chen; Zhongqi Fan; Xiaodong Sun; Wei Qiu; Yuguo Chen; Jianpeng Zhou; Guoyue Lv
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

2.  Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn's Disease.

Authors:  Ahmed Abomhya; Mohammed Mahmoodurrahman; Salman Ayaz; Hossam Hamad; Farrah Khan
Journal:  Gastroenterology Res       Date:  2022-04-12

3.  Multidimensional Impact of Mediterranean Diet on IBD Patients.

Authors:  Fabio Chicco; Salvatore Magrì; Arianna Cingolani; Danilo Paduano; Mario Pesenti; Federica Zara; Francesca Tumbarello; Emanuela Urru; Alessandro Melis; Laura Casula; Massimo Claudio Fantini; Paolo Usai
Journal:  Inflamm Bowel Dis       Date:  2021-01-01       Impact factor: 5.325

4.  Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.

Authors:  Scott McHenry; Ankita Tirath; Richard Tsai; Yeshika Sharma; Avegail G Flores; Nicholas O Davidson; Kathryn J Fowler; Matthew A Ciorba; Parakkal Deepak
Journal:  Inflamm Bowel Dis       Date:  2020-11-19       Impact factor: 5.325
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.